As of 2007, heart disease happened to be the leading cause of death in the United States with almost 1 million Americans dying of cardio vascular disease each year - adding up to the alarming 42 percent of all deaths!
Generally, no symptoms of early cardiovascular abnormalities show up, which is a major problem that adds to the rising crises.
The relieving part of it is that heart disease’s progression can be slowed down; rather even reverse damage to the heart and blood vessels, if treated early! This new finding, in fact is a great relief-provider in itself to all the heart patients, in their early stages.
Drug blocking a hormone detrimental to the blood vessels and the heart, Valsartan is found to not just slow progression of heart disease, but also reverse early cardiovascular disease in asymptomatic patients with high risk.
This first study showing the early interference’s help in a cardiovascular abnormality’s regress can relief the society of the no. 1 killer and help organize awareness campaigns for early diagnosis of the disease to considerably lower the number of heart disease deaths.
